Tag Archives: PrEP

Glasgow outreach service shows the feasibility of PrEP for people who inject drugs

A proactive, outreach-based service for people who inject drugs has successfully delivered the HIV prevention medication PrEP in the midst of Glasgow’s HIV outbreak, Dr Ceilidh Grimshaw of Sandyford told the virtual British HIV Association conference this week. Very few PrEP programmes for people who inject drugs have reported results and ongoing engagement with healthcare… Read More »

Almost one in ten HIV PrEP users report buying antibiotics for STI prevention, raising concerns over potential antibiotic resistance

An online community survey conducted in the UK shows that 9% of HIV PrEP users are buying antibiotics to prevent themselves from getting STIs. The survey results from 2019 were published in last month in the Sexually Transmitted Infections journal. Those buying antibiotics were more likely to have had at least five condomless sexual partners… Read More »

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »

UnitedHealthcare spurns Gilead’s newer PrEP drug Descovy as Truvada generic looms: report

UnitedHealthcare has a history of limiting HIV drug costs, including offering cash incentives to patients who opt for low-priced regimens. Now, in a potentially major blow to HIV giant Gilead Sciences, the insurer has set its eyes on one of the California drugmaker’s new therapies. Gilead’s new HIV PrEP option, Descovy, will no longer be covered… Read More »